A health expert has warned that taking certain tablets for an extended period of time could increase your risk of developing ...

Many people in the United States take medications called proton pump inhibitors, or PPIs, to help with heartburn, acid reflux ...

Americans who took proton pump inhibitors, or PPIs, for four-and-a-half years or longer were 33% more likely to develop ...

After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...

The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Regularly taking this tablet could increase the risk of developing the degenerative disease by as much as a third.

Doctors have warned about the risks of long-term use of the drug, which has also been linked to strokes, bone fractures and ...

Scientists found that people who take proton pump inhibitors, or PPIs, for four-and-a-half years or more were 33 per cent ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

Braintree Laboratories, a part of Sebela Pharmaceuticals® and a leading manufacturer of gastroenterology pharmaceutical products, today announced positive topline results from two pivotal US Phase 3 ...